XTRA:BAYNPharmaceuticals
Bayer Roundup Settlement And Supreme Court Case Reframe Litigation And Valuation
Bayer (XTRA:BAYN) has proposed a multibillion dollar nationwide class action settlement aimed at resolving current and future U.S. lawsuits tied to alleged cancer risks from Roundup.
The settlement framework seeks broad claimant participation and court approval to bring more predictability to Bayer's long running glyphosate litigation exposure.
At the same time, the U.S. Supreme Court is hearing a key appeal that could influence how federal law interacts with state level failure to warn...